NCT03660618 is a NA clinical trial of laser speckle flowgraphy in Hypertension, sponsored by Randy Kardon.

Who is sponsoring NCT03660618?

NCT03660618 is sponsored by Randy Kardon.

What drugs are being tested in NCT03660618?

Interventions in NCT03660618: laser speckle flowgraphy.

What condition does NCT03660618 study?

NCT03660618 studies Hypertension, Heart Failure, Vascular Ischemia, Burns, Chemotherapy Effect, Radiation Injuries, Uveitis, Scleritis, Multiple Sclerosis, Autonomic Neuropathy, Stroke, Intracranial Hemorrhages, TIA, Migraine, Headache, Pain.

Is NCT03660618 still recruiting?

NCT03660618 is currently terminated. Last updated 10 May 2023.

Are results published for NCT03660618?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2023-05-10 · How we verify

NCT03660618

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LSFG-SKIN, Laser Speckle Flowgraphy

Terminated NA Results posted Last updated 10 May 2023

What this trial tests

NA trial testing laser speckle flowgraphy in Hypertension in 1 participant. Terminated before completion.

Timeline

23 May 2017

Primary endpoint
2 March 2019

2 March 2019

Quick facts

Lead sponsor	Randy Kardon
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	1
Start date	23 May 2017
Primary completion	2 March 2019
Estimated completion	2 March 2019
Sites	1 location across United States

Drugs / interventions tested

laser speckle flowgraphy

Conditions studied

Hypertension — all drugs for Hypertension →
Heart Failure — all drugs for Heart Failure →
Vascular Ischemia — all drugs for Vascular Ischemia →
Burns — all drugs for Burns →

Sponsor

Randy Kardon

Who can join

Adults 18 to 90, any sex, with Hypertension or Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this project is to quantify normal and abnormal skin blood flow regionally in different areas of the body(face, extremities, over burns and wounds) at baseline and over time in response to treatment or environmental changes, such as temperature, light and pressure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other Randy Kardon trials

Trials by the same sponsor.

NCT03694626 — Objectively Diagnose and Monitor Treatment of Light Sensitivity · NA · recruiting
NCT03475173 — New Non-invasive Modalities for Assessing Retinal Structure and Function · NA · recruiting
NCT03475147 — Smartphone Flicker Fusion Test for Patients With Optic Disorders. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03660618 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Randy Kardon
Last refreshed: 10 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03660618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing